PCSK9操纵脂肪代谢和癌症中的免疫微环境
Chaochu Cui1, Aiwei Yan1, Shengming Huang1,2
1Henan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
OncoTargets and therapy
|April 1, 2025
概括
蛋白转化酶亚素/素9型 (PCSK9) 通过调节脂质代谢和免疫细胞功能,影响癌症的进展和免疫逃避. 了解PCSK9 的理解
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究的研究.
背景情况:
- 癌症是全球主要的死亡原因,免疫疗法显示出显著的前景.
- 蛋白转化酶亚提利辛/凯辛9型 (PCSK9) 是血脂水平的关键调节剂.
- 新出现的证据强调PCSK9在癌症生物学和免疫调节中的作用.
研究的目的:
- 综合审查PCSK9在癌症中的多方面的作用.
- 阐明PCSK9影响瘤发生,进展,免疫逃脱和耐药性的机制.
- 突出PCSK9作为瘤学的潜在治疗点.
主要方法:
- 在癌症中对PCSK9进行临床前和临床研究的文献综述.
- 分析PCSK9对脂质代谢和免疫细胞信号通路的影响.
- 对PCSK9参与瘤发育和治疗耐药性的当前知识的综合.
主要成果:
- PCSK9通过脂质代谢调节瘤进展期间的免疫反应.
- PCSK9影响各种免疫细胞的命运和功能 (例如,炎症,MHC,TCR信号传递).
- PCSK9与癌症免疫逃脱和获得的耐药性有关.
结论:
- PCSK9在癌症免疫和进展方面发挥着重要的,以前被低估的作用.
- 向PCSK9可能提供新的策略来增强癌症免疫疗法和克服耐药性.
- 进一步研究PCSK9的免疫调节功能是必要的临床转化.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cell-surface Signaling
51.3K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.3K


